ArticleFrontiers in medicine2026
Parametrial involvement in cervical cancer is associated with systemic inflammatory indices: a retrospective observational study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this study is to evaluate the association between parametrial invasion (PI) and systemic inflammatory indices in patients with cervical cancer, exploring whether routinely available hematological markers reflect local tumor spread. Methods: A retrospective observational study was conducted including patients with cervical cancer treated with surgery and/or radiotherapy and/or chemotherapy between July 2023 and December 2025. Patients were stratified according to the presence or absence of PI, as determined by histopathological or radiological assessment. Systemic inflammatory indices derived from pre-treatment blood tests included neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic inflammatory response index (SIR), and systemic inflammation response index (SIRI). Comparisons between groups were performed using non-parametric tests. Receiver operating characteristic (ROC) curves were used to evaluate the standalone discriminative ability of each inflammatory index. Logistic regression models were applied to assess associations with PI. To reduce information loss and limit model instability in this exploratory cohort, inflammatory indices were analyzed as continuous variables. Adjusted analyses were performed using separate clinically predefined models, each including one inflammatory index together with depth of stromal infiltration and fornix involvement. Results: A total of 79 patients were included in the analysis. PLR, MLR, NLR, and SIRI were significantly higher in patients with PI compared with those without PI, whereas SIR did not differ significantly. In analyses stratified by the extent of PI, significant differences were observed for MLR, NLR, and SIRI. In unadjusted logistic regression models, PLR, MLR, NLR, and SIRI were associated with PI. After adjustment for depth of stromal infiltration and fornix involvement in separate clinically predefined models, only MLR remained significantly associated with PI (adjusted OR per 0.1-unit increase: 1.986; 95% CI: 1.095-3.603; Conclusion: Parametrial invasion in cervical cancer is associated with measurable alterations in systemic inflammatory indices, reflecting the host response to locoregional tumor spread. Among the evaluated indices, MLR retained an association with PI after adjustment for clinically relevant local spread parameters. However, the modest standalone discriminative performance and exploratory nature of the analysis preclude the use of these indices as independent diagnostic tools. Further prospective validation is required before any clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.